default author photo

Katja C. Weisel

University of Hamburg - Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology

Hamburg

Germany

SCHOLARLY PAPERS

2

DOWNLOADS

114

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Depth of Response to Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (Isa-KRd) in Front-Line Treatment of High-Risk Multiple Myeloma: Interim Analysis of the GMMG-CONCEPT Trial

Number of pages: 34 Posted: 01 Mar 2021
Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University of Tuebingen, Department of Hematology, Oncology and Bone Marrow Transplantation, Klinikum Chemnitz, Department of Internal Medicine, Charité University Medicine Berlin, Department of Hematology, Oncology and Palliative Care, Klinikum Bielefeld Mitte, Department of Internal Medicine, Hematology and Oncology, Johanniter Krankenhaus Bonn, Department of Hematology and Stem Cell Transplantation, University of Duisburg-Essen, Department of Hematology and Oncology, St. Antonius Hospital Eschweiler, Department of Hematology, Oncology and Immunology, University Hospital of Giessen and Marburg, Internal Medicine V and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Department of Internal Medicine III, University Medical Center Mainz, Department of Hematology, Oncology and Gastroenterology, Maria Hilf Kliniken, Department of Oncology, Hematology and Stem Cell Transplantation, Klinikum Osnabrück, Asklepios Tumorzentrum Hamburg, Institute of Human Genetics, Heidelberg University, Center for Clinical Trials, University Hospitals Tübingen, Division of Biostatistics, German Cancer Research Center (DKFZ), Division of Biostatistics, German Cancer Research Center (DKFZ), Universitatsklinikum Hamburg-Eppendorf, Internal Medicine V and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University of Hamburg - Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology and Independent
Downloads 92 (730,864)

Abstract:

Loading...

2.

Real-World Data on Outcome of Burkitt Lymphoma and Burkitt Leukemia Treated According to the Gmall B-All/Nhl 2002 Protocol: A Tertiary Center Experience

Number of pages: 19 Posted: 30 Jan 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Hamburg - Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University of Hamburg - University Medical Center Hamburg-Eppendorf, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 22 (1,424,331)

Abstract:

Loading...

Burkitt lymphoma, Burkitt leukemia, outcomes, GMALL B-ALL/NHL, Non-Hodgkin Lymphoma